Sartorius AG SRT

Opportunities include automated closed systems, AI-enabled quality control, single-cell and cell therapy workflows, precision medicine, advanced diagnostics and emerging-market expansion.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cell Isolation/Cell Separation Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The market research report examines the global Cell Isolation/Cell Separation Market, which is projected to reach USD 6.97 billion in 2026 and grow a

Reusable Bioreactors Gain Momentum as Biologics, Personalized Therapies and Vaccine Production Drive Automation and Scalable ManufacturingDublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Reusable Bioreactors Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Reusable Bioreactors Market to Reach USD 24.7 Billion by 2035 as Biologics Manufacturing Expands The global reusable bioreactors market was valued at US

Cell Culture Media Market Gains Momentum as Serum-Free Formulations, Biologics and Cell Therapies Drive DemandDublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Media Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Cell Culture Media Market to Reach USD 10.8 Billion by 2035, Driven by Biopharmaceutical Innovation The global cell culture media market was valued at USD 3.9 billion in 2025 and is

Biologics, stricter purity rules and flexible manufacturing are driving demand for single-use, automated and continuous filtration, advanced membranes and sustainable systems.Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Pharmaceutical Filtration - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Pharmaceutical Filtration was estimated at US$8.0 Billion in 2025 and is projected to reach US$23.4 Billion by 2032, growing at a CAGR of 16.7% f

Bioreactors Market Gains Momentum as Single-Use Systems, Automation and Advanced Therapies Reshape BiomanufacturingDublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Bioreactors Market Opportunity, Growth Drivers, Industry Trend Analysis and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Bioreactors Market to Reach USD 38.9 Billion by 2035 as Advanced Biomanufacturing Expands The global bioreactors market was valued at USD 13.8 billion in 2025 and is projected to reach

Europe’s cell therapy sector is shifting to closed, automated systems, creating opportunities in AI monitoring, modular scale-up, CAR-T/ATMP production and decentralized manufacturingDublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Europe Automated and Closed Cell Therapy Processing Systems Market Size, Share & Industry Analysis Report by Type, Scale, Workflow, Country Outlook and Forecast, 2026-2033" has been added to ResearchAndMarkets.com's offering. The Europe automated and closed cell therapy pr

Demand is rising for real-time biomolecular analysis in drug discovery and diagnostics, driven by SPR/BLI advances, automation, high-throughput screening and biomarker research.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-free Array Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Label-free Array Systems was valued at US$1.8 Billion in 2024 and is projected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.6% from 2

AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-Free Detection - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Label-Free Detection was valued at US$553 Million in 2024 and is projected to reach US$847 Million by 2030, growing at a CAGR of 7.4

Demand is rising for single-use, automated and real-time aseptic sampling as biopharma and food producers prioritize contamination control, continuous manufacturing and compliance.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Aseptic Sampling - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Aseptic Sampling was estimated at US$867.4 Million in 2025 and is projected to reach US$1.3 Billion by 2032, growing at a CAGR of 6.3% from 2025 to 2

Sartorius (XTRA:SRT3) has drawn fresh attention after announcing a partnership with Ireland’s National Institute for Bioprocessing Research and Training to build a large-scale training center for intensified and fully continuous bioprocessing in Dublin. Recent catalysts around Sartorius, including its Dublin training center announcement and a run of investor conference appearances in September 2026, arrive as momentum picks up. The stock has a 7 day share price return of 9.13% and a 1 year...

Opportunities center on real-time, high-throughput drug discovery and diagnostics, driven by SPR/BLI advances, AI analytics, CRO adoption, improved sensitivity and Asian localization.Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) -- "Label-Free Array Systems Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global label-free array systems market is experiencing strong growth, supported by expanding pharmaceutical research and development, increased investment in life sciences

The global single-use bioreactors market is forecast to grow from USD 5.43 billion in 2026 to USD 9.58 billion by 2031, at a 12.0% CAGR. Growth is driven by biologics, biosimilars, vaccine manufacturing, CDMO outsourcing, and flexible bioprocessing. Bioproduction and monoclonal antibodies led the market in 2025, while Asia Pacific is expected to grow fastest through 2031. Key players include Sartorius, Danaher, Thermo Fisher Scientific, and Merck KGaA.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "

The global Advanced Bioreactor Systems Market is projected to grow from USD 4.2 billion in 2026 to USD 11.8 billion by 2036, at a CAGR of 10.9%. Growth is driven by biologics manufacturing, cell and gene therapies, single-use bioreactors, continuous bioprocessing, and AI-based process control. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes market segments, regional opportunities, technology trends, and key companies including Sartorius, Thermo

When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioprocessing unit missed expectations, signaling continued softness in broader biopharma demand. The news hit European supplier Sartorius AG, which traded lower […]

Thermo Fisher stock led a medtech rebound Thursday, easing investors' fears of continued malaise for the medical research and tools realm.

Sartorius AG (SARTF) reports robust sales and profitability growth, driven by bioprocess solutions, despite facing tariff and market volatility challenges.

Biopharmaceutical production led applications in 2025, while sera, media and reagents dominated consumables. Asia-Pacific is expected to record the fastest growth through 2031. Key players include Thermo Fisher Scientific, Danaher, Sartorius, Merck and Corning. Cell Culture Market Cell Culture Market Dublin, July 23, 2026 (GLOBE NEWSWIRE) -- The "Cell Culture Market by Consumables, Vessels, Equipment, Application, Competition - Global Forecast to 2031" has been added to ResearchAndMarkets.com's

Sartorius Aktiengesellschaft (ETR:SRT) reported higher first-half sales, improved profitability and stronger cash generation, while management said underlying demand in its bioprocessing and laboratory businesses remains intact despite tariff-related accounting effects and some delayed orders in adv